DatasetName,NEDD4L_S(137) NEDD4L_S(182) NEDD4L_S(303) NEDD4L_S(334) NEDD4L_S(340) NEDD4L_S(385) NEDD4L_S(420) NEDD4L_S(421) NEDD4L_S(446) NEDD4L_S(447) NEDD4L_S(449) NEDD4L_S(451) NEDD4L_S(455) NEDD4L_S(459) NEDD4L_S(464) NEDD4L_S(471) NEDD4L_S(475) NEDD4L_S(479) NEDD4L_S(483) NEDD4L_S(487) NEDD4L_S(516) NEDD4L_S(582) NEDD4L_S(727) NEDD4L_T(302) NEDD4L_T(318) NEDD4L_T(367) NEDD4L_T(451) NEDD4L_T(581),NEDD4L_S(308) NEDD4L_S(342) NEDD4L_S(384) NEDD4L_S(448) NEDD4L_S(538) NEDD4L_T(473),NEDD4L_S(13) NEDD4L_S(307) NEDD4L_S(512) NEDD4L_T(301) NEDD4L_T(339) NEDD4L_Y(485)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,,,
FSO2013_Ratio M/L normalized Rep3,0.5260770698623529,0.6507525274599405,
SR2019_MCF7_Biol_repl_3,0.5091392042812851,0.5943328315737298,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,0.5207039539852232,0.607382973343445,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,,,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,0.5109864423171516,0.6119200109974127,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,0.5101959918338362,,
HS2024_6_B_T3,,,
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,0.5237962966391516,0.5637162419067011,
SR2019_MDAMB231_Biol_repl_4,0.5236044402900139,0.6072007935079008,
GF2025_P2_Sph,0.5162358979787421,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,,,
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,,,
FSO2013_Ratio M/L normalized Rep1___1,0.5205690972027183,,
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,0.5112493214004009,,
RB2022_5_PreEndurance,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,0.6103969574856616,
EP2017_Untreated R#4 normalized log2 ratio,0.5190563275071948,0.5805929042756632,0.4122435934519537
WZ2023_Pu_010_30min,0.5145007987615904,0.6146390194031189,0.4218168502723209
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,0.5042394283316864,0.621042331674924,
RB2022_8_RecoveryEndurance,0.5143827682318788,,
KBE2022_Log2_Ex_14_U,,,
FSO2013_Ratio M/L normalized Rep3___3,0.49097554897524426,,
AH2018_TMTMS3_1_C,0.5132209080210776,0.6102766985815092,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,0.5087380554626525,,
RB2022_5_PreSprint,,,
PG2020_Intensity 8h_C,,0.597343679687591,
AH2018_SILAC_MR_2_N,0.5088509930359489,0.6204670468474226,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,0.5152740192704321,,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,,,
FSO2013_Ratio H/L normalized Rep2___2,0.5325210343930372,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5161748700636137,0.5916350070677491,0.4300485957623023
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,,,
GF2025_P6_Sph,,,
RB2022_2_PreSprint,,,
ZX2022_CB treated Replicate 3,0.5111883659921618,,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,0.5152537315550807,0.6150474079712791,0.42086072671442665
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,,,
KBE2022_Log2_Ex_34_U,,,
WZ2023_Pu_005_10min,0.5128694941175252,0.6149687922899049,0.41964326511763606
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,0.5756289972996106,
WZ2023_Pu_025_30min,0.5128755947023121,0.6174650798376632,0.4184303479150606
AH2018_SILAC_MR_2_X,0.5089382591974971,0.6226352925220177,
HS2024_4_PD_T2,,,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,,,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,,,
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,,,
EJN2021_3_Rest_Basal,,,
CR2017_Ratio Replicate 1.3,,0.5777815999335428,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,0.5152501182954355,0.6107696942199751,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,0.48720731490085356,0.6199763735762923,
HS2024_7_PD_T2,,,
FSO2013_Ratio H/L normalized Rep1___1,0.5138294202994305,0.6239330740319952,
AH2018_LFQ_1_C,0.5056491874900978,0.6181408201483607,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,,,
HS2024_3_B_N1,,,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,0.5162962591376243,0.6156265351497736,0.4223286479272328
CK2022_11 40-1,,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,0.4940135140180744,0.619402033844016,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,0.5368034717646759,0.6110781965965518,
FSO2013_Ratio H/L normalized Rep2,0.5238288259057893,0.6113953761237522,
WZ2023_Pu_005_20min,0.5142149012463418,0.6159200399045534,0.4222562827469806
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,,,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,0.5867614394282277,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,0.5084611196463306,0.6209891070163576,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,0.5015008626267167,0.5969126686577994,
HS2024_9_B_T2,,,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,,,
FSO2013_Ratio M/L normalized Rep3___2,0.50138241447907,0.6204093986833058,
SR2019_BT549_Biol_repl_3,,,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,,,
RB2022_2_PreStrength,,,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,,,
CK2022_1 200-1,,,
PG2020_Intensity Mock_10h_D,,0.6116572826677512,
SR2019_MCF10A_Biol_repl_2,,0.6020090861837876,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,0.5060122004994927,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5078657809399091,0.6314773496065381,0.37786987217458456
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,,0.5744314631356174,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,,0.5840501121276593,
PG2020_Intensity 2h_C,,0.597496652147416,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,0.51136452494243,,
KBE2022_Log2_Ex_8_T,,,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,,,
RN2012_L11,,,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,,,
AH2018_LFQ_M_2_C,0.5201121655991889,0.6265894153480912,
CK2022_3 40-1,,,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,,,
YA2020_Reporter_intensity_Cancer_No.5,0.5119714114890498,,
HH2022_Reporter intensity 8,0.5151951232697476,,0.40617286730621643
ZQ2022_N2,0.515619437507697,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,0.5071857891873631,0.6028640916415187,
EJN2021_5_Rest_Basal,,,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,0.5117095115456577,0.6108143452176203,
YA2020_Reporter_intensity_Normal_No.1,0.5133337137243725,,
HS2024_3_B_T1,,,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,,,
RB2022_1_PostEndurance,0.5148945184946953,,
CR2017_Ratio Replicate 3,0.5033500643159342,0.5630120100856716,
SR2019_Hs578T_Biol_repl_3,,0.5851293496240882,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,0.512257475343573,,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,,,
HS2024_8_I_T3,,,
CF2017_EOC 3,,0.5959432869693733,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,,,
DL2023_12h-2,,0.5467530150081318,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,0.5138476516800791,0.6149156584046958,0.42344335891527457
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,,,
KS2014_Intensity N3,0.5169234375572616,0.5987637611881687,
RB2022_4_RecoveryEndurance,,,
RB2022_5_RecoveryEndurance,,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,0.5025609036758149,0.6138495405690788,
FSO2013_Ratio H/M normalized Rep2,0.4878601464740961,0.6340699274183564,
RAM2015_Log2 A,0.5020340820773422,0.6234715709356761,
HS2024_8_PD_T1,,,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,,0.6142255351329067,
KS2014_Intensity E15_2,0.5320056893591849,0.6116421705116433,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,,0.5909136461908994,
HS2024_7_I_T1,,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,,0.5630640412176678,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,,,
AH2018_SILAC_M_3_X,0.5156627367194526,0.6109631774117755,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,,,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,0.5063559807390201,0.6169936789267897,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,0.5095321146547777,,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,,,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,0.5192145913184407,0.5809085293476647,0.41246328996125897
HS2024_6_B_N1,,,
KBE2022_Log2_Ex_27_T,0.5160431302165218,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,0.5115838273675847,,
AH2018_SILAC_IT_3_X,0.49992572755109865,0.622554921697262,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,,0.5769258831095122,
FSO2013_Ratio M/L normalized Rep2,0.525659782969905,0.6031557265551201,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,0.5150276278180751,,0.3973839035315099
SR2019_HCC1954_Biol_repl_2,0.5128325611256802,0.6091943725896499,
CK2022_14 40-1,,,
RB2022_6_PreSprint,0.5178476408884249,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,,0.6042802365521,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,0.5093451128441467,,
DL2023_control-1,,,
AR2021_ALG 10 μM,0.5229106424671127,,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,0.5093014992976114,0.6144432057773631,
EJN2021_4_Rest_Ins,,,
RN2012_H05,0.5120527445259005,0.5296234521068354,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,0.516677601936646,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,,,
EJN2021_1_Rest_Ins,,,
HH2022_Reporter intensity 3,0.5081474460846965,,0.42589894613067864
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,0.5138697818405326,0.6135981060882713,
JW2021_After_3,,,
GF2025_P8_Sph,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,0.4902829484367933,0.6197424926721007,
CK2022_11 200-1,,,
CK2022_12 200-1,,,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,0.5141585421230167,,0.41914968187012974
WZ2023_Su_010_20min,0.5139476652984998,0.6153953173761114,0.42096822013696933
AH2018_TMTMS2_2_N,0.5174541721307196,0.6149836007469632,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,,
AH2018_TMTMS3_Pool,0.5087878478304108,0.5984207699347924,
KS2014_Intensity N4,0.5080429302296334,0.6000702950283454,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,0.5921554584836906,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,,0.6057495943948378,
CK2022_14 200-1,,,
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,0.5168867836831255,,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,0.5117547497786626,0.595633868638879,
AST2020_anti-CD3+PDL2.2,,,
PG2020_Intensity Mock_10h_A,,0.6099373061018935,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,,,
SR2019_LM2_Biol_repl_4,0.52331554230043,0.6126776113054978,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,,,
GF2025_P1_Adh,0.5150280655793835,,
GF2025_P1_Sph,0.5003764654023939,,
EJN2021_5_Ex_Basal,,,
HS2024_7_I_T3,,,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.5149064490257977,0.6126257162716443,0.4226781126724835
CF2017_EOC 1,,0.6138882948196996,
CK2022_3 200-1,,,
AH2018_LFQ_IT_3_C,0.4999780611304715,0.6184848747768523,
SR2019_Hs578T_Biol_repl_2,,0.5956975780517355,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,0.5118938627335685,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,,,
HS2024_5_B_T1,,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,,
SR2019_MDAMB231_Biol_repl_2,0.5311556438369595,0.5964585903700154,
HS2024_3_B_T2,,,
RB2022_6_PreStrength,0.5046212774615173,,
CK2022_2 40-1,,,
RB2022_1_PostSprint,0.510695202050255,,
CK2022_4 200-1,,,
JW2021_Before_2,,,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,,,
AR2021_ALG 1 μM,0.5169331795583968,,
HS2024_4_B_T1,,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,,,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,,0.6077529431322694,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,,,
CK2022_9 16-1,,,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,,,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,0.4988163681646585,0.6006795598876867,
CK2022_16 16-1,,,
FS2019_db/db3,0.5130889528510398,,0.4248459784473908
CK2022_15 40-1,,,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.515219210259139,0.6160225991210152,0.4221955266945108
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,,,
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,0.494049219227728,0.6194079714735666,
HS2024_5_PD_T3,,,
AH2018_TMTMS3_3_X,0.5090591913387624,0.6003889931674745,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,,,
AH2018_LFQ_M_1_N,0.5084977438368969,0.628207736406756,
KBE2022_Log2_Ex_27_U,0.517089498621669,,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,0.4919618671734059,0.6143591020303757,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,0.5088448632088929,,
YA2020_Reporter_intensity_Normal_No.4,0.5141290009098246,,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,,0.6074459269494237,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,,,
RN2012_L13,0.5117240434239846,0.5297930383709807,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,,,
SR2019_SKBR3_Biol_repl_3,0.5074441561877069,0.5948755580450338,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,0.5040322382064859,0.6348657436822022,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,,,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,0.5189290367909192,,
HH2022_Reporter intensity 6,0.5154860839679467,,0.426622643402174
RB2022_2_RecoveryStrength,,,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,0.5115733318045356,,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,0.5072297270034439,0.5702320169843572,
AH2018_TMTMS2_3_X,0.5142328964879213,0.6118774584585288,
GF2025_P3_Adh,0.5170384305697633,,
SR2019_JIMT1_Biol_repl_2,,0.578150458478663,
AH2018_TMTMS2_1_C,0.5191620469804381,0.6114683744789121,
RM2024_Intensity D0-1___2,,,
LY2019_P4+,0.5063131295914438,,
KBE2022_Log2_Ex_19_U,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,,,
LG2023_GSK3α-3_intensity,,0.5861550306739637,
YA2020_Reporter_intensity_Cancer_No.1,0.5134489159493864,,
AST2020_Control,,,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,0.625445553073189,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,0.5163318234489656,0.5956043358688679,
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,,,
RB2022_7_RecoverySprint,0.5112475990100612,,
YA2020_Reporter_intensity_Normal_No.3,0.5126584248776958,,
HS2024_8_B_T2,,,
AH2018_LFQ_1_X,0.509995461734583,0.6180039409605133,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,0.517492131509753,0.610350619614469,
HH2022_Reporter intensity 1,0.5087681157865603,,0.4257745417080543
HH2022_Reporter intensity 2,0.507767322695581,,0.4278854162585102
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,0.5120681836914361,,
SR2019_MCF7_Biol_repl_1,,0.5852303642740063,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,,,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,
EP2017_Untreated R#2 log2 ratio,0.5106066222127222,0.580452302685328,0.41233763648537414
SR2019_LM2_Biol_repl_3,0.5268718129293108,0.6173664872609871,
RB2022_4_RecoveryStrength,,,
CR2017_Ratio Replicate 2,0.5165486564113845,0.5887837135270424,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,0.5196939065048124,0.6080981616024611,
AR2021_KD 72h,0.4962189588545877,,
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,0.5095855898584135,,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,0.5045188035257964,0.5998309690674626,
KBE2022_Log2_Ex_9_U,0.5089762631783283,,
AH2018_SILAC_M_3_N,0.5122470481253197,0.6108131481035162,
KBE2022_Log2_Ex_13_T,,,
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,0.5089217718513835,0.5859909902100096,
PG2020_Intensity Mock_10h_C,,0.6104969067261806,
CF2017_OSE 29,,0.5994246682889265,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,,
HS2024_7_B_N2,,,
PG2020_Intensity 10h_A,,0.5441495629676737,
RN2012_L12,,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,0.5175579483957216,0.6098894939772197,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,,,
FSO2013_Ratio H/M normalized Rep1___1,0.5005093123077423,0.6333564829873105,
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,,,
RB2022_7_RecoveryEndurance,0.5159210547012686,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,,,
TM2022_S2.12h.B,,,
RN2012_L15,,,
KS2014_Intensity pY_PV3,,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,,0.603425361356929,
FSO2013_Ratio H/M normalized Rep2___2,0.48695403228628237,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,,,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,0.5202492552580072,0.6038807804708143,0.4292695009292509
RB2022_1_PreSprint,,,
HS2024_4_I_N1,,,
CK2022_7 200-1,,,
CK2022_5 200-1,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,0.6060202957372597,
FSO2013_Ratio H/L normalized Rep2___1,0.5242010245504455,0.6116643608529339,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,,
AH2018_LFQ_2_C,0.5136440227695561,0.6238244142768982,
AH2018_SILAC_MR_1_X,0.509782686125779,0.6228615102258016,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,,,
AH2018_SILAC_3_C,0.517570935928778,0.6100004296889662,
EJN2021_5_Rest_Ins,,,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,0.48729203027109275,0.6332434407259666,
CK2022_4 16-1,,,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,0.5071296657661015,0.5924051586633197,
EJN2021_2_Ex_Ins,,,
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,0.5137017927180049,0.626072236814312,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,,0.594775555185347,
FSO2013_Ratio H/L normalized Rep3,0.5298744514382049,0.5817090363827626,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,,,
KBE2022_Log2_Ex_9_T,0.508420704489881,,
AH2018_SILAC_IT_2_N,0.5115586233678212,0.6144643100205636,
AH2018_SILAC_IT_1_X,0.5053144079836024,0.62138018528193,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,,,
UK2020_UA_2,,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,,,
WZ2023_Pe_025_20min,0.5139175864539596,0.6147505418095499,0.4195085916504166
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,0.5182926867377995,0.6248408848768084,
HS2024_4_I_N2,,,
AH2018_TMTMS2_3_N,0.5113695278090623,0.613984565717666,
RN2012_H06,,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,,,
WZ2023_Su_005_30min,0.514845686978014,0.6181937153446321,0.420968725943942
SR2019_HCC1419_Biol_repl_4,0.5046434529520981,0.6014733873620847,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,,0.5790526755601704,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,0.5012066766898469,0.5690017105015258,
WZ2023_Su_025_10min,0.5130085480222981,0.6178306567600034,
AH2018_LFQ_IT_4_X,0.5152434555311947,0.610721613181911,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,,,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,0.5144207362386728,0.6176365099993553,0.422489469285041
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,0.5175589192240247,0.5831674518380783,0.4435676375229731
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,0.5190587095335439,,
KS2014_Intensity,0.5374568614039751,0.606924767058371,0.41531849034231466
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,,0.5928941499743845,
LY2019_P7+,0.5107363412380378,,
EP2017_Untreated R#1 normalized log2 ratio,0.5133210368020312,0.5959215375200669,0.47209595602826554
RN2012_L10,,,
PG2020_Intensity 4h_C,,0.6028169228266673,
EP2017_Mitotic R#3 normalized log2 ratio,0.5048551535401916,0.6518227332402572,0.3997155394903416
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,,,
RB2022_8_PostStrength,,,
AH2018_SILAC_IT_2_X,0.5000368498995508,0.6222194565421129,
HS2024_4_B_T3,,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,,,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,,,
KBE2022_Log2_Ex_6_U,,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,0.4973533969399215,0.5982042461730632,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,0.5671753616050389,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,,,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5075157662111283,0.6309145004401429,0.3785045796809867
GF2025_P9_Sph,,,
CK2022_6 200-1,,,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,0.5167724572227603,0.5883226426874442,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,0.4996350701244453,0.5870065591672152,
HS2024_4_I_T2,,,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,,,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,0.5301199122948781,0.6106360591674821,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,0.5778192654906794,
PG2020_Intensity 2h_D,,0.6052521668076395,
EP2017_Untreated R#3 normalized log2 ratio,0.5076075372944105,0.6271838723608334,0.45749000990996486
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,,,
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,,,
RB2022_7_PostEndurance,,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,0.5850845139807488,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5167418642125212,0.5786206607146681,0.4149807859124192
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,0.621196747434078,
AH2018_SILAC_2_C,0.4999916876123724,0.6185610917850837,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,,,
KBE2022_Log2_Ex_29_T,0.5115603804043906,,
HS2024_7_I_T2,,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,,,
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,,,
FR2021_Intensity.M,,,
RB2022_2_PostSprint,,,
AH2018_SILAC_MR_3_N,0.5115487875175211,0.6236388332366741,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,,0.6064641740545481,
PG2020_Intensity CT_C,,0.6059479744914613,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,0.5118439504400152,,0.4162167586413965
KS2014_Intensity pY_PV4,,,
KBE2022_Log2_Ex_39_U,,,
EP2017_Untreated R#3 log2 ratio,0.5078060766385897,0.6279151892174999,0.45800597301952123
RB2022_2_PostStrength,,,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,,,
HS2024_8_PD_T2,,,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,,,
FR2021_Norm.Intensity.G,,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,,,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,,,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,0.5144540187735209,,
CR2017_Ratio Replicate 2.3,,0.5846721690215511,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,0.5157887064827551,,
YA2020_Reporter_intensity_Normal_No.2,0.5125783582871465,,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,,,
HS2024_3_PD_T3,,,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,,
RAM2015_Log2 C,0.527353075136286,0.6368222849020683,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,0.48555806128092127,,
AH2018_LFQ_M_2_N,0.5119782160138782,0.6277367210409209,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,,,
CK2022_2 16-1,,,
RAM2015_Log2 B,0.4915270487876216,0.622648228821986,
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,0.5314713846666637,0.5646937673410989,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,,,
UK2020_HCM_5,,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,0.5757864419409188,
HS2024_7_PD_T3,,,
PG2020_Intensity Mock_10h_B,,0.6061730060542099,
WZ2023_Su_025_30min,0.5128320021652217,0.618566035052052,0.41724110094866873
AH2018_LFQ_4_N,0.5170634490253697,0.6209812031981449,
CR2017_Ratio Replicate 1.2,,0.5754166353005805,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,0.509023201437681,,
HS2024_8_I_N1,,,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,0.516087126065238,,0.4303538619159702
AH2018_SILAC_M_1_X,0.5057703704020912,0.6147982740036432,
RB2022_7_PreEndurance,0.5182448347149716,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,,
LY2019_P6+,0.5079894198038616,,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,,,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,,,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,0.5006934851876791,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,0.5104742996310214,0.5930477326005102,
SR2019_Hs578T_Biol_repl_4,,0.5832932137776953,
RB2022_8_PreStrength,,,
KS2014_Intensity C5,0.5202286272518873,0.6048997840163853,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,0.510737620436949,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,
GF2025_P9_Adh,,,
RB2022_3_PostStrength,0.5107472102546887,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,,,
SR2019_BT549_Biol_repl_1,,,
AH2018_LFQ_M_4_N,0.521732768772423,0.6238983918104811,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,,0.5969984144484212,
AH2018_LFQ_2_X,0.5051601805114849,0.621549846290354,
PG2020_Intensity 2h_B,,0.6035809327024232,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,,,
KS2014_Intensity E15_3,0.5345984139538699,0.6132530396712328,
GF2025_P3_Sph,0.5160117892249761,,
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,0.511003814329125,0.6118241879735454,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,0.5229892917568976,0.6171201550080557,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,0.5155476587087816,0.6136939637372815,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,,,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,,,
ZQ2022_N1,0.5164037704720873,,
LY2019_P6-,0.5050222571326172,,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,,,
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,,,
AH2018_LFQ_3_N,0.5064107999589129,0.6241892722832336,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,,,
UK2020_UA_1,,,
KBE2022_Log2_Ex_13_U,,,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,
RB2022_1_RecoverySprint,0.5179231971285315,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,0.5998963666557163,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,,,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,,0.6058908670836106,
SR2019_BT549_Biol_repl_2,,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,,,
HS2024_5_PD_T2,,,
WZ2023_Su_025_20min,0.514411928870518,0.6182608752724218,0.4211680545298169
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,0.5094948873732977,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,0.5953419716145957,
FSO2013_Ratio H/L normalized Rep1,0.5118715456184926,0.6223307203914394,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,0.5991870667879349,
CK2022_13 40-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,,,
PG2020_Intensity 10h_D,,0.5657500633028915,
RB2022_8_PreEndurance,0.5142016408389875,,
HS2024_3_B_N2,,,
EJN2021_4_Ex_Ins,,,
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,,,
EP2017_Pervanadate R#3 log2 ratio,0.5164798989953756,0.5925305500410069,0.4310853468139373
FSO2013_Ratio M/L normalized Rep1___3,0.5371442501557739,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,0.5219366154228129,,
AH2018_SILAC_MR_3_C,0.5107005591764227,0.6274430262093849,
AH2018_LFQ_M_4_C,0.5053227393864959,0.6167368545558904,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,0.6229964449172404,
RN2012_H04,0.5130674223742614,0.5917365764734291,
CK2022_6 40-1,,,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,,,
LY2019_P3-,0.5178625377082814,,
FR2021_Intensity.A,,,
EJN2021_3_Ex_Ins,,,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.5107412338683999,0.6130252489962329,0.42133335473451394
HS2024_8_PD_T3,,,
EJN2021_3_Ex_Basal,,,
AST2020_Control.1,,,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,,0.6004632938207827,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,0.5138059404097248,0.617655469305563,0.4203495069072755
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,,,
RB2022_1_RecoveryStrength,0.5138070954088413,,
SR2019_HCC1954_Biol_repl_4,0.5098561744235222,0.6027707127610763,
FR2021_Norm.Intensity.N,,,
HS2024_5_B_N1,,,
FSO2013_Ratio H/M normalized Rep3___3,0.5342985293095796,,
AH2018_TMTMS2_2_C,0.5183540870173998,0.6125893333601734,
RB2022_4_PreSprint,,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,0.5041851701925949,0.6026719496643793,
HS2024_8_I_N2,,,
RB2022_3_RecoveryStrength,0.5110263261427747,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,0.5062748269958831,0.6133840527074713,
LY2019_P8+,0.5165366763803949,,
RB2022_2_RecoveryEndurance,,,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,0.5138046430775246,,
KS2014_Intensity pY_PV1,,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,0.5851309067904306,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,0.5106282917088879,0.6203464070871922,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,,,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,,0.604134140200422,
LY2019_P2-,0.5155736635084139,,
AH2018_LFQ_IT_1_X,0.509050708025183,0.61443250991742,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,0.5133466718887175,,
WZ2023_Pe_005_20min,0.512942845629396,0.6125283488966831,0.41944343582539695
AST2020_Control.2,,,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,,,
SR2019_MCF10A_Biol_repl_4,,0.5924656159983394,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,,0.6160337434746838,
HS2024_5_B_T2,,,
HS2024_6_I_T1,,,
HS2024_5_B_T3,,,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,0.5108857647772514,,
AH2018_TMTMS3_3_N,0.5035277250315165,0.6013351628895555,
SR2019_HCC1419_Biol_repl_2,0.5046576806834587,0.5719123493963941,
FR2021_Intensity.N,,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,0.5093387022981605,0.6211729160323739,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,0.5058540742670847,0.6526806589880938,0.40243556161686506
KBE2022_Log2_Ex_36_T,0.509959153858463,,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.5138013517346568,0.615765699512885,0.4219185569401489
KS2014_Intensity C2,0.5180295819768194,0.6062229000254457,
FSO2013_Ratio H/L normalized Rep1___2,0.5084717358473826,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,,,
CK2022_9 200-1,,,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,,,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,,,
RBK2021_1332T Late,,,
LY2019_P1-,0.5154126649586518,,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,,,
HS2024_3_I_T3,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,0.6236918679627733,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,0.5305314790015402,0.6108612321131064,
ZQ2022_C3,0.5096237799579869,,
EJN2021_3_Rest_Ins,,,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,,,
FSO2013_Ratio H/M normalized Rep3___2,0.5076134089040231,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,0.513572430884822,0.5964072616025942,0.47252404229830963
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,0.5131883480654988,0.6154884408388116,0.41890674852045784
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,0.5036123593923921,0.5883625734322112,
HS2024_5_I_T3,,,
KS2014_Intensity N1,0.5205585136189496,0.6054592298285266,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,0.5079470228541477,0.5842249703904102,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,0.508053277543183,0.6197800350605709,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,,0.59818181389803,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,0.5093742505773521,0.6261180777471075,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,,,
HS2024_5_B_N2,,,
HS2024_5_I_N1,,,
HS2024_6_I_N1,,,
AR2021_KD 48h,0.49631744858771515,,
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,0.5083850067778138,,
HS2024_5_I_T1,,,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,0.5168817140412337,0.6071172760407763,
AST2020_anti-CD3,,,
SR2019_MDAMB231_Biol_repl_1,0.5273865598905809,0.6080305744480093,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.5115408603602497,0.6129330496249151,0.4151437619339946
KBE2022_Log2_Ex_29_U,0.5116917139675952,,
HS2024_7_B_T1,,,
AH2018_LFQ_M_2_X,0.5140090142821498,0.6248095738477306,
AH2018_LFQ_IT_4_N,0.511682301728324,0.6107484662335897,
CK2022_15 200-1,,,
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,0.5898171570169862,
LY2019_P2+,0.5063748454467356,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,,,
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.5142887394605199,0.6150789716884565,0.42022196137425677
RN2012_H01,,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,,,
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,,0.568462582837359,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5172931611035515,0.5824881092356738,0.44293905196177047
HS2024_8_B_T3,,,
YA2020_Reporter_intensity_Cancer_No.3,0.5129053403079682,,
KBE2022_Log2_Ex_44_U,,,
WZ2023_Pe_010_20min,0.5154150969931525,0.6134129354210637,0.4216493879457918
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,0.5109895565608703,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,
RCJD2014_10min_mean,,,
KS2014_Intensity C1,0.5233214220620886,0.613096268959083,
FSO2013_Ratio H/M normalized Rep3___1,0.5237602825784438,0.6080492452562275,
AH2018_SILAC_M_3_C,0.517938026381557,0.6100668623360114,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,0.5021192875163953,0.618788174151944,
AH2018_SILAC_M_2_X,0.4907706831487029,0.6186213731766302,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,,,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.5128894878676148,0.6163428943905221,0.41640739927283804
PG2020_Intensity 6h_C,,0.5993001615202939,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,0.5041375697960094,0.6270245227662352,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,0.5157389367231284,0.6128210883695365,
CK2022_15 16-1,,,
CK2022_3 16-1,,,
LY2019_P4-,0.5099065850942984,,
FSO2013_Ratio H/L normalized Rep3___2,0.53630676621135,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,,,
GF2025_P8_Adh,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,0.5130546843767178,,
CK2022_10 16-1,,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,,
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,0.5081603181558451,0.6324898450844193,0.38281229869629624
EJN2021_2_Ex_Basal,,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,0.6308257417979016,
CF2017_FTE 16,,0.6154285943261987,
AR2021_L41 10 μM,0.5220069110290578,,
CF2017_EOC 2,,0.5942936855164093,
RB2022_6_PostEndurance,0.5031527591073317,,
AH2018_SILAC_1_N,0.5025857510524381,0.6137952121067227,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,,,
RB2022_7_PreSprint,0.5119545708080996,,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,,,
CK2022_6 16-1,,,
ZX2022_CB treated Replicate 1,0.5110691469799102,,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,0.5074142429575366,,0.4255404547762996
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,0.5082702575037239,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,0.5170786330091496,0.6136852671217328,
AR2021_L41 1 μM,0.519301280151423,,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,0.5168026390461036,0.6155022488904346,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,0.5106377108052571,,
KS2014_Intensity C4,0.5391758531500287,0.6057911978441083,0.41644304367837837
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,0.5095856193601407,,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,0.5272142278831045,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,0.5912626265845727,
HS2024_7_B_T2,,,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,0.5155324774348112,0.6232573368297875,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,0.5124868994964967,,
FSO2013_Ratio H/M normalized Rep2___3,0.48973877288556367,,
RB2022_8_PreSprint,0.5159318844404351,,
AH2018_SILAC_IT_3_C,0.5070930267955239,0.6145860533980473,
WZ2023_Pu_025_10min,0.5129052076700872,0.6170131537371751,0.41903030924273116
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,0.5233826076946865,0.6361645876358107,
SR2019_JIMT1_Biol_repl_4,,0.5724729642111853,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,,0.5966582690608268,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,0.514335849435686,0.6125246508816969,0.4234138779860485
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,0.4902752952026333,0.6197514053768959,
KS2014_Intensity C6,0.5249856703777404,0.6051205168213832,0.4210944392276306
ZQ2022_N3,0.5161430184882301,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,,,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,0.5111830284934109,,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,,,
AH2018_SILAC_IT_2_C,0.5119328178904746,0.61523705636224,
CK2022_5 40-1,,,
AH2018_LFQ_3_X,0.5131097003042819,0.6207198541707949,
UK2020_UA_3,,,
LY2019_P7-,0.5222124716230495,,
GF2025_P5_Adh,0.5156527856900788,,
RB2022_1_PostStrength,0.5165707087147433,,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,0.53021034386529,0.5820766040419505,
SR2019_HCC1954_Biol_repl_3,0.4948308140654992,0.6072491152150967,
CR2017_Ratio Replicate 2.2,,0.5731073538057346,
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,,,
ZQ2022_C1,0.5109501914861602,,
CR2017_Ratio Replicate 2.1,0.5367484643511865,0.570776804153508,
PG2020_Intensity CT_B,,0.6072830257831897,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,0.5079841619131934,0.6232113673926835,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,0.5119113070330915,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,0.5130491818198045,0.6199286575883748,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,0.5135153404852544,0.6238416203315377,
YA2020_Reporter_intensity_Cancer_No.4,0.5118903427184432,,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,0.5164468113353576,,
RB2022_2_PreEndurance,,,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,,,
CK2022_14 16-1,,,
AST2020_anti-CD3+PDL2,,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,,,
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,,,
FSO2013_Ratio H/M normalized Rep1___2,0.48921792544112963,,
HS2024_8_I_T1,,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,
EP2017_Mitotic R#2 log2 ratio,0.5084612474791318,0.6332958397583648,0.3814558677256294
AH2018_TMTMS2_1_X,0.5156363411672136,0.6118764206085647,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,0.5909828958565855,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,,,
HS2024_6_I_N2,,,
HH2022_Reporter intensity 4,0.5147624036454232,,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,,0.6140140737970632,
HS2024_4_I_T3,,,
AH2018_SILAC_1_X,0.5090664200822728,0.6143700299311529,
PG2020_Intensity 10h_B,,0.5677967859382883,
AH2018_TMTMS3_1_X,0.5112961935679745,0.5925003111731574,
CF2017_FTE 14,,0.5954784789179105,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,,0.6022868055818638,
SR2019_HCC1419_Biol_repl_3,0.5009107340953606,0.6034951533054546,
KBE2022_Log2_Ex_14_T,,,
EP2017_Untreated R#2 normalized log2 ratio,0.5104313506645658,0.5802019159567429,0.412185697845789
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,0.5115150142647017,,
HS2024_5_I_N2,,,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,0.5170510413124895,0.5796576871013934,0.41586603452933035
AS2011_Ratio H/L Normalized RNAi_2_1,,,
